throbber
(12) UK Patent Application (19) GB {ill 2198 041l13‘lA
`(43) Application published 3 Jun 1983
`
`{21} Application No 8706977
`
`(22) Date of filing 24 Mar 193?
`
`(30) Priority data
`(31) 8823228
`
`(32) 26Nov19B6
`
`(33) GB
`
`(51)
`
`INT CL‘
`A51K 31:’195 31fl35 31i7D 311715 35478
`
`(52) Domestic classification [Edition J]:
`A53 180 231 20X 20‘! 230 23X 233’ 26Y 303 30X
`30Y 401 402 403 406 «WY 421 423 426 42Y 481
`462 483 -{BY 502 503 5OY 550 55Y 576 57‘! 555
`SBY 596 59‘! 616 61Y JA
`U18 1328 A53
`
`
`
`(71) Applicant
`lnstltut Blologll Marya Dalnavostoclmogo Nauchrlogo
`Tsentra Altadernll Nauk SSSH
`
`(56) Documents cited
`Nona
`
`(Incorporated In USSR)
`
`Vladivostok. prospekt 100 list, Vladlvosloltu 159,
`Union at Soviet Socialist Republics
`
`(53) Field of search
`A58
`06E
`Selected US specifications from IPC sub-class
`A51K
`
`Nauohno-lssledovalelsky Instllul Sadovodstva
`Vinogradarstva I Vlnodella
`
`(|n¢mpgm.ad in ussn)
`
`Tbilisi. Union or Sovlat Socialist Republics
`
`Giaptarovich Ohekutishuiti
`lzratl llskovloh Brekhrnarl
`
`Alexandr Evgenlevich Bulanov
`Mira lvanovna Polozhentseva
`
`(72)
`
`_
`Inventors
`(74) A99” afldm Address hr Sam“
`Levan Alexandrovlch Mudzhlrl
`”'*""* 5‘ °‘°",‘
`_
`Gla Gennadlevlch Alkhazaslwlll
`f_:'n°g°:':‘:;’é;; g'L';"'°""»
`Elena llilnlchna Kalatozishvili
`
`
`(54) Inhibiting alcohol addiction
`
`(5?) Compositions {or inhibiting alcohol addiction contain: leukoanthooyans, catochins. flavanols, lignin, reducing sugars,
`pectin. free aminoaclds. organic acids. sterols. methylsiorols, dimethystorols. lignanes, lignano glycosidss. phenolic acids,
`phenol aldehydes and alkyllerulates. Alcoholic beverages containing these compositions are also disclosed.
`
`‘VW086LZ89
`
`USP|abs EXHIBIT 1005
`
`_;‘L-4 '
`
`‘-oval;
`"
`
`USPlabs EXHIBIT 1005 .
`
`

`
`21980~*E1
`
`Composition Inhibiting Pathological
`
`Addiction to Alcohol
`
`Field of the Invention
`
`The present invention relates to compositions for
`
`5
`
`inhibiting the development of
`
`a pathological addiction
`
`to alcohol, and to processes for their manufacture.
`
`Background of the Invention
`
`Known in the art is an alcoholic bitter liqueur
`
`comprising the following ingredients, kg/1.000
`
`10
`
`decalitres:
`
`hralia root
`
`Eleutherococcus extract
`
`schizandra (fresh berry)
`
`sugar
`
`15
`
`Natural honey
`
`Tint
`
`2.5
`
`20
`
`345
`
`200
`
`50
`
`25
`
`Aqueo—a1coho1ic liquid .
`
`the balance.
`
`9‘
`
`[See "Formulations of Liqueur-Vodka Products and
`
`Vodkas". "Legkaya i Pistschevaya Promyshlennost" (Light
`
`

`
`2
`
`and Food Industry} Publishing House. Moscow. 1981,
`
`13.133).
`
`_.L3"V4'.a._gI
`
`Also known in the art is an alcoholic bitter liqueur
`
`including the following ingredients. kg/1.000 decalitres:
`
`U:
`
`Eleutherococcus extract
`
`Schizandra (fresh berry)
`
`schizandra (seeds)
`
`Natural honey
`
`Tint
`
`200
`
`92
`
`0.6
`
`50
`
`30
`
`10
`
`Aqueo-alcoholic liquid
`
`the balance.
`
`{See “Formulations of
`
`liqueur-Vodka Products and
`
`Vodkas“, Light and Food Industry Publishing House.
`
`Moscow, 1981. p.206.)
`
`The prior art alcoholic liqueurs are produced by way
`
`of blending the starting components, a successive
`
`introduction.
`
`into the resulting blend. of an aqueo-
`
`alcoholic liquid. settling of
`
`the resulting mixture and
`
`filtration thereof.
`
`As it is seen from the above—specified formulations,
`
`20
`
`the latter contain a biologically active extract of
`
`Eleutherococcus which lowers the toxic effect of ethanol
`
`in a living organism.
`
`
`
`

`
`2
`
`However.
`
`low taste properaties of the prior art
`
`beverages caused by a limited content of aromatic
`
`compounds. as well as a "pharmaceutical" aftertaste due
`
`to the presence of Eleutherococcus extract, high costs
`
`5
`
`of
`
`the starting ingredient — Eleutherococcus extract —
`
`and limited availability of this plant do not enable a
`
`wide scale of consumption of these prior art beverages.
`
`The present
`
`invention resides in the provision of a
`
`composition inhibiting the development of a pathological
`
`10
`
`addiction to alcohol which. according to the present
`
`invention, comprises the following ingredients. mg/g:
`
`leukoanthocyanes
`
`catechins
`
`Elavanols
`
`15
`
`lignin
`
`reducing sugars
`
`pectin
`
`free amino acids
`
`organic acids
`
`20
`
`sterols
`
`methylsterols
`
`dimethylsterols
`
`lignans
`
`7
`
`lignan glycosides
`
`25
`
`phenolic acids
`
`219-270
`
`153-187
`
`81-99
`
`63-83
`
`216-264
`
`18-22
`
`27~33
`
`36-44
`
`4.5-5.5
`
`1.35-1.65
`
`1.93-2.42
`
`13.5-16.5
`
`9-11
`
`13.5-16.5
`
`

`
`phenolic aldehydes
`
`alkylferulates
`
`4.5-5.5
`
`4.5—5.5
`
`-2:"
`
`'
`
`The composition according to the present invention
`
`advantageously comprises a combination of compounds
`
`LJ1
`
`occurring in nature.
`
`The composition has a pronounced
`
`capability of affecting processes or ethanol metabolism
`
`without switching to unfavourable routes of
`
`the
`
`organism's utilization of ethanol: as a result.
`
`the
`
`process of formation of a physical dependence on alcohol
`
`10
`
`is delayed,
`
`the level of its consumption is lowered and
`
`certain alcoholic behaviour excesses disappear.
`
`Furthermore,
`
`the composition according to the present
`
`invention is not
`
`toxic and is safe upon prolonged
`
`consumption: it has positive organoleptic
`
`,_.. LJI
`
`characteristics and can be useful as a food additive to
`
`alcoholic and alcoho1—free beverages.
`
`In a preferred aspect,
`
`the present
`
`invention resides
`
`in that an alcoholic beverage comprising sugar, citric
`
`acid.
`
`a tint and an aqueous—alcoholic liquid. according
`
`20
`
`to the present
`
`invention also incorporates fruit alcohol
`
`and a composition of substances inhibiting the
`
`development of a pathological addiction to alcohol
`
`containing, mg/g:
`
`leukoanthocyanes — 219-270, catechins
`
`— 153—l87. flavanols — 81-99.
`
`lignin — 68-83,
`
`reducing
`
`35
`
`sugars - 216-264. pectin — 18-22. free amino acids
`
`4
`
`wfi.
`
`

`
`5
`
`-27-33. organic acids — 36-44. sterols - 4.5-5.5,
`
`methylsterols — 1.35-1.65, dimethylsterols — 1.98-2.42.
`
`lignans « 13.5-16.5.
`
`lignan glycosides - 9-11. phenolic
`
`acids - 13.5-16.5. phenol aldehydes — 4.5—Sl5.
`
`alkylferulates ~ 4.5-5.5.
`
`the ingredients being present
`
`in the following proportions. kg per 1.000 decalitre of
`
`the beverage:
`
`the above—specified composition
`
`473-493
`
`fruit alcohol 40°
`
`4,950—5,050
`
`10
`
`sugar
`
`citric acid
`
`tint
`
`95-105
`
`1.8-2.2
`
`28—32
`
`aqueous—a1coho1ic liquid
`
`the balance.
`
`The alcoholic beverage according to the present
`
`invention is capable of
`
`inhibiting a pathological
`
`addiction to alcohol and has high organoleptic
`
`properties — the tasting test of the beverage is not
`
`less than 9.1 points.
`
`This alcoholic beverage may be produced by a process
`
`20
`
`comprising blending of sugar. citric acid and a tint.
`
`followed by the addition.
`
`to the resulting blend. of an
`
`aqueo—a1coho1ic liquid. settling and filtration. wherein
`
`according to the present invention blended are 473—493
`
`
`
`

`
`kg of
`
`a composition inhibiting a pathologic addiction to
`
`alcohol, 4.950—S.0SO kg of
`
`a 40° fruit alcohol. 95-105
`
`kg of sugar. 1.8-2.2 kg of citric acid and 23-32 kg of
`
`tint:
`
`to the resulting blend the aqueous~alcoholic
`
`liquid is added in the amount required for the
`
`preparation of 1.000 decalitre of
`
`the beverage;
`
`prior
`
`to settling and filtration the final blend is subjected
`
`to a triple successive thermal
`
`treatment for 5-8 hours
`
`at a temperature of 70—80°C and to cooling to attain a
`
`10
`
`temperature within the range of from 0 to —10°C.
`
`Other subjects and advantages of the present
`
`invention will now be more fully apparent from the
`
`following detailed description of
`
`the alcoholic beverage
`
`and the process for producing same according to the
`
`present
`
`invention.
`
`The beverage according to the present invention
`
`contains, kg per 1,000 decalitre of
`
`the beverage:
`
`Composition inhibiting a pathological
`
`addiction to alcohol
`
`473-493
`
`20
`
`40° fruit alcohol such as pear alcohol,
`
`apple alcohol, plum alcohol.
`
`tangerine
`
`alcohol
`
`sugar
`
`4.9S0~S,050
`
`95-105
`
`ll‘
`
`
`
`

`
`citric acid
`
`tint
`
`1.8-2.2
`
`23-32
`
`an aqueo—a1coho1ic liquid
`
`the balance
`
`(comprising a mixture of water
`
`and ethanol
`
`in a desired ratio)
`
`The desired ratio of ethanol and water in this
`
`mixture depends on the final strength of
`
`the produced
`
`beverage.
`
`10
`
`15
`
`when the alcoholic beverage of the present
`
`invention
`
`is consumed.
`
`the process of
`
`the formation of a physical
`
`dependence on ethanol
`
`in the organism is inhibited.
`
`Furthermore. drinking of this beverage is not
`
`accompanied by such negative effects as a "hang~over"
`
`syndrome.
`
`The tasting test value of
`
`the above alcoholic
`
`beverage according to the present invention is not less
`
`than 9.1 points.
`
`An improvement
`
`in organoleptic
`
`properties is attained due to an increased content of
`
`aromatic substances.
`
`in particular esters of derivatives
`
`20
`
`of aromatic acids and higher alcohols. as well as due to
`
`interaction of aldehydes. ketones, acetals and
`
`alkylferulates being present
`
`in the beverage composition.
`
`An alcoholic beverage according to the present
`
`
`
`

`
`B
`
`\_JI
`
`10
`
`invention is produced in the following manner. There
`
`are blended:
`
`a composition inhibiting the development
`
`of a pathological addiction to alcohol. a fruit alcohol,
`
`sugar. citric acid, a tint. whereafter the resulting
`
`blend is added with an aqueo—ethano1ic liquid in an
`
`amount necessary to obtain the beverage of 40%
`
`strength.
`
`Then the resulting blend is subjected to a
`
`successive heat
`
`treatment for three times at a
`
`temperature of 70—80°C for a period of 5-8 hours.
`
`Thereafter.
`
`the blend is cooled for a period sufficient
`
`to acquire a temperature within the range of
`
`from 0 to
`
`-10°C.
`
`Then the thus—produced beverage is filtered.
`
`allowed to stand for 10 days at a temperature varied
`
`within the range of
`
`from 10 to 45°C and again filtered.
`
`I--‘ U!
`
`Production Example 1
`
`There are blended 483 kg of
`
`a composition
`
`containing. mg/g:
`
`leukoanthocyans — 245.0. catechins —
`
`180.0. flavanols — 90.0.
`
`lignin - 75.0.
`
`reducing sugars
`
`— 261.7. pectin — 20.0, free amino acids — 30.6, organic
`
`20
`
`acids — 39.0, sterols - 5.0. methylsterols — 1.5.
`
`dimethylsterols - 2.2.
`
`lignans — 15.0.
`
`lignan glycosides
`
`— 10.0. phenolic acids — 15.0. phenol aldehydes — 5.0,
`
`alkylferulates — 5.0. 40° pear alcohol
`
`— 4.990 kg. sugar
`
`— 105 kg. citric acid — 2.2 kg. tint — 32 kg
`
`
`
`

`
`9
`
`r.
`
`and an aqueo—ethanolic liquid in an amount required to
`
`obtain a blend following heat treatment at the
`
`temperature of 75°C for 6 hours. Thereafter the blend
`
`is cooled to a temperature of 0 to 2°C.
`
`Then the
`
`5
`
`beverage is filtered. settled for 10 days at a
`
`temperature within the range of from 1o to 15°C.
`
`The final product is filtered while being bottled.
`
`Production Example 2
`
`A beverage is produced by blending 473 kg of a
`
`10
`
`composition containing the following ingredients in the
`
`amounts specified hereinbelow. mg/g:
`
`leukoanthocyans —
`
`219, catechins — 153. flavanols — 81.
`
`lignin — 68.
`
`reducing sugars — 345.17. pectin - 16. free amino acids
`
`- 27. organic acids - 36. sterols — 4.5, methylsterols —
`
`15
`
`1.35. dimethylsterols — 1.98,
`
`lignans — 13.5,
`
`lignan
`
`glycosides — 9, phenolic acids — 13.5, phenol aldehydes
`
`- 4.5, alkylferulates — 4.5.
`
`It also contains. as indicated in Example 1. 4.950
`
`kg of a 40°C plum alcohol. 95 kg of sugar. 1.3 kg of
`
`20
`
`citric acid. 28 kg of a tint and an aqueo—ethanolic
`
`liquid in an amount sufficient to obtain a blend with
`
`'?
`
`the strength of 40 volt. Thereafter the blend is
`
`subjected to a triple successive heat treatment for 5
`
`

`
`10
`
`hours at the temperature of 80°C.
`
`Then the blend is
`
`cooled for a period of
`
`time sufficient to acquire a
`
`temperature of 0 to 1°C.
`
`Then the beverage is filtered,
`
`allowed to stand for 10 days at a temperature of 20 to
`
`22°C.
`
`The final product is again filtered when being
`
`bottled.
`
`Production Example 3
`
`There are blended 493 kg of
`
`a composition containing
`
`10
`
`the following ingredients in the amounts specified
`
`hereinbelow, mg/g:
`
`leukoanthocyans - 2?0. catechins —
`
`137, flavanols — 99,
`
`lignin — B3.
`
`reducing sugars —
`
`197.5, pectin - 22.
`
`free amino acids - 33. organic acids
`
`— 44, sterols - 5.5. methylsterols — 1.65,
`
`dimethylsterols — 2.42.
`
`lignans — 16.5.
`
`lignan
`
`glycosides — 11. phenolic acids — 16.5, phenol aidehydes
`
`— 5.5, alkylferulates — 5.5. a 40° tangerine alcohol
`
`—
`
`5.050 kg, sugar
`
`— 105 kg. citric acid — 2.2 Kg, tint —
`
`32 kg, an aqueo—a1coholic liquid in an amount sufficient
`
`20
`
`to obtain a blend of
`
`a 40 vo1.% strength. Thereafter
`
`the blend is subjected to a triple successive heat
`
`treatment for 5 hours at the temperature of 80°C.
`
`Then
`
`the blend is cooled for a period of
`
`time surficient for
`
`it to acquire a
`
`temperature of B—l0°C.
`
`Then the
`
`
`
`

`
`ll
`
`beverage is filtered, allowed to stand for 10 days at a
`
`temperature of
`
`from 40 to 45°C.
`
`The final product is again filtered when being
`
`bottled.
`
`Further objects and advantages of
`
`the present
`
`invention will now become more fully apparent from the
`
`following detailed description of a composition
`
`inhibiting the development of a pathological addiction
`
`to alcohol with reference to examples illustrating its
`
`10
`
`particular embodiments.
`
`15
`
`20
`
`The composition according to the present invention
`
`preferably contains, as leukoanthocyanes,
`
`leuko-
`
`dolphinidine.
`
`leukocyanidine and leukopelargonidine. As
`
`catechins it contains {—)epigallocatechin.
`
`(+)gallocatechin, {-}epicatechin, {+) catechin and
`
`{—)epicatechinga11ate.
`
`As flavanols the composition
`
`according to the present invention contains
`
`kaempfero1-3-monoglucoside, quercetin-3—monog1ucoside.
`
`myricetin—3—monog1ucoside and astragalin. As sugars it
`
`contains D—g1ucose. D—fructose. saccharose, raffinose,
`
`arabinose. xylose. As free amino acids the composition
`
`according to the present invention contains lysine.
`
`histidine, arginine. aspartic acid,
`
`threonine, serine,
`
`glutamic acid. proline, glycine, alanine,
`
`
`
`

`
`12
`
`cystine, valine. methionine.
`
`isoleucine,
`
`leucine.
`
`tyrosine and phenylalanine. As organic acids it
`
`contains tartaric acid, malic acid, citric acid.
`
`5
`
`ascorbic acid. n-ketoglutaric acid,
`
`fumaric acid,
`
`LJI
`
`galacturonic acid. glyceric acid. glycolic acid,
`
`glycouronic acid. oxalic acid. succinic acid. shikimic
`
`acid. As sterols the composition according to the
`
`present
`
`invention contains 8—cetostero1. stigmasterol.
`
`kaempesterol.
`
`As methylsterols it contains
`
`10
`
`obtusifoliol. citrostadienol. As dimethylsterols it
`
`incorporates d—amyrin, B—amyrin.
`
`lnpeol,
`
`taraksterol,
`
`taraxasterol, germanicol. As
`
`lignans the
`
`composition according to the present invention contains
`
`oxymatairesinol. Natairesinol. pinoresionol.
`
`liovyl,
`
`13
`
`isolariciresinol and olivyl.
`
`As
`
`lignan glycosides it
`
`contains quetinol arabinoside and querinol xyloside.
`
`As
`
`phenolic acids it contains paraoxybenzoic acid.
`
`protocatechinic acid. gallic acid. vanillic acid and
`
`syringic phenolic acids.
`
`As phenolic aldehydes the
`
`20
`
`composition according to the present
`
`invention contains
`
`vanilline. syrinqic aldehyde. sinapic aldehyde and
`
`coniferyl aldehyde.
`
`As alkylferulates it contains alkyl
`
`esters of ferulic acid with the alcohol moiety being
`
`represented by octadecanol, eicosanol. docosanol.
`
`25
`
`tetracosanol. hexacosanol.
`
`The above—mentioned composition of
`
`the
`
`f:
`
`

`
`'-t.‘
`
`13
`
`herein—before—listed ingredients can also be obtained in
`
`the form of natural1y—occurring complexes of
`
`biologically active substances of
`
`the vegetable origin.
`
`The above-mentioned composition of the heroin-
`
`before—listed ingredients is soluble in water, ethanol
`
`and aqueous—alcoholic solutions.
`
`The composition according to the present
`
`invention
`
`has a low toxicity:
`
`LD50 is 36.5 ml per 1,000 g of
`
`body—mass of a rat.
`
`10
`
`15
`
`20
`
`We have carried out pharmacological studies of
`
`the
`
`effect of the composition according to the present
`
`invention on processes of ethanol consumption and on the
`
`formation of a physical dependence on animals and human
`
`beings.
`
`Under conditions of a chronic experiment
`
`(15 weeks)
`
`on mature male rats of Wistar line the level of ethanol
`
`consumption was studied under the conditions of free
`
`choice between water and a 15% ethanol. Prior thereto
`
`the rats were tested for resistance to ethanol by the
`
`"side posture" procedure upon an intraperitoneal
`
`H"-‘
`
`administration of
`
`a 25% ethanol at the rate of 4.5 g/kg
`
`of
`
`the body mass of
`
`the animals.
`
`In the experiment rats
`
`with similar characteristics of a high tolerance towards
`
`
`
`

`
`14
`
`ethanol were used. Later on the animal were placed into
`
`cases with calibrated drinking bowls under conditions of
`
`free choice between a 15% ethanol and water. and the
`
`daily consumption of
`
`the liquids was recorded.
`
`The control group was composed of animals (12 rats)
`
`that consumed a 15% ethanol.
`
`In the test group (12 rats) the composition
`
`according to the present invention was added to a 15%
`
`ethanol
`
`in the drinking bowl
`
`in the amount of 1 ml per
`
`10
`
`50 ml of 15% ethanol. After 13 weeks of active
`
`alcoholization the animals were deprived of
`
`the access
`
`to alcohol for 10 days (deprivation period) and then the
`
`amount of consumed solutions was recorded again.
`
`The
`
`experimental data are shown in Table 1.
`
`In the group of control animals the deprivation
`
`period proceeded with withdrawal phenomena which
`
`manifested in a changed behaviour of
`
`the animals, signs
`
`of
`
`tremor were recorded. a moderate dishevelling of hair
`
`was noted.
`
`At
`
`the same time.
`
`in the control group no
`
`20
`
`withdrawal symptoms were observed.
`
`The character of consumption of a 15% ethanol under
`
`free choice conditions in the control group was
`
`different from that of consumption of a 15% ethanol with
`
`‘I.
`
`
`
`

`
`1;‘.
`
`the composition according to the present invention in
`
`the test group. Beginning from the 3th weeks a clearly
`
`15
`
`pronounced trend towards reduction of ethanol
`
`consumption in combination with the composition
`
`according to the present invention was observed and
`
`after deprivation this difference was exceeding 100%.
`
`An important indicator of a formed physical dependence
`
`on ethano1_in the control group was an increased rate of
`
`ethanol consumption after a 10-days‘ deprivation by
`
`12%.
`
`In the test group the consumption of ethanol in
`
`combination with the composition according to the
`
`present invention after deprivation remained at the same
`
`level.
`
`TABLE 1
`
`Effect of the composition according to the present
`
`invention on the amount of consumed 15% ethanol on a
`
`daily basis (in ml/kg of 1 animal's bodyweight) under
`
`free choice conditions
`
`10
`
`15
`
`ill’
`
`
`
`

`
`Tnble 1
`
`rameter
`
`Time of consumption (in weeks)
`
`
`
`33.0
`3.55
`
`32-2
`4_og
`
`31.0
`2_g3
`
`91
`
`1
`9
`3
`11
`10
`9
`n
`7
`6
`5
`4
`15
`13
`12 ~
`1. Amount of
`20.9
`20.1
`22.5
`25.0 20.3 25.5 22.5 20.0 24.0 20.2 29.1
`29.4 24.1 Henri-'29.4
`consumed 15%
`1.06
`1.18
`2.29
`2.05 1.01.97 2.32 1.332.115 2.25 1.25
`3.44 1.29 "“E§°“ 3
`,2
`ethanol (con-
`days
`trul group)
`2. Amount of
`consumed 15%
`ethanol wlth
`addition of
`the compualv
`tion of this
`invention
`(1 ml per
`50 ml of et-
`hanol)
`
`34.0 25.9 26.6 29.3 15.3 10.9 22.0 22.0 20.0 13.0 E:f”ii3.0
`3_11
`2,5} 2.96 1.3
`1.49 1.16 2.1? 1.66 2.42 2.12 gig“
`2.41
`0
`
`0.0
`
`5
`
`0.0
`
`5
`
`0.01 0.2
`
`0.1
`
`-
`
`-
`
`0.01 0.001
`0_ou1
`
`0.2 0.1 0.05 1
`days U.0D
`
`time of consumptlcn (in weeks)
`
`

`
`17
`
`Addition,
`
`to a 15% ethanol. of
`
`the-composition
`
`according to the present invention under conditions of a
`
`lonq—time forced alcoholization (38 months) with the
`
`absence of water
`
`in the food diet has resulted in a
`
`substantial redistribution of animals in groups of
`
`alcohol consumption (Table 2).
`
`TABLE 2
`
`Effect of
`
`the composition according to the present
`
`invention on distribution of rats according to the rate
`
`10
`
`of consumption of a 15% ethanol (in per cent) {forced
`
`alcoholization).
`
`F-——__flH*___—_h__Fh—T__"—_"__—_—_”**'"‘”""1F‘”**”*"‘“
`fl
`_
`Alcoholization time
`
`uroups of animals
`
`8 months
`
`6 months
`
`3 months
`
`
`
`Low-drinking (20-60
`ml per 1,000 g of
`the bodymess)
`
`25/45
`
`73/76
`
`57/79
`
`Medium-drinking
`
`(so-so ml per 15000g I
`
`of the bodymsss
`
`31/12
`
`22/21
`
`21/15
`
`Heavily-drinking
`above 80 ml per 1,000g
`12/5
`5/3
`43/13
`of the bodymass)
`
`
`-1'}
`
`Q}
`
`*) Note:
`
`In the numerator — consumption of a 15%
`
`ethanol.
`
`in the denominator — consumption of a 15%
`
`ethanol with the addition of a composition according to
`
`the present
`
`invention.
`
`
`
`

`
`18
`
`The conditions of this experiment contemplated an
`
`individual control of consumption of test solutions in
`
`L!‘
`
`groups of animals:
`
`among the rats administered with
`
`alcohol
`
`incorporating the composition according to the
`
`present invention the number of heavily-drinking animals
`
`was certainly smaller.
`
`To avoid possible organoleptic effect of the
`
`composition according to the present
`
`invention on the
`
`level of ethanol consumption under free—choice
`
`10
`
`conditions parallel experiments have been carried out
`
`where the composition was introduced intragastrically.
`
`not into the test solution.
`
`The test results turned to
`
`be identical
`
`irrespective of
`
`the routes of
`
`administration of
`
`the composition according to the
`
`present
`
`invention.
`
`Gas-liquid chromatography was used to determine the
`
`amount of ethanol
`
`in blood of animals of
`
`the test and
`
`control groups that were given the test solution for the
`
`period of
`
`3 months.
`
`90 minutes prior to slaughtering
`
`20
`
`the animals they were introperitoneally administered
`
`with a 25% ethanol
`
`in combination with the composition
`
`according to the present invention in the ratio of 1:50
`
`{test group).
`
`Q:
`
`
`
`

`
`19
`
`The test results (Table 3) point to an essential
`
`increase (by more than 4 times) of ethanol in theblood
`
`of animals that were previously administered for a long
`
`time with the composition according to the present
`
`invention.
`
`The rate of elimination of ethanol from blood
`
`depend. first of all. on activity of alcoho1dehydro-
`
`genase (ADG) which has been studied against the
`
`background of an acute and chronical alcoholic
`
`10
`
`intoxication.
`
`Upon a sing1e—time intraperitoneal administration,
`
`to animals of a 15% ethanol
`
`in the does of 4.5 g/kg of
`
`the body mass, 30 minutes thereafter the activity of
`
`alcohol dehydrogenase is 3.51 mM/min/l relative to the
`
`intact group;
`
`the composition additive according to the
`
`present invention inhibits activity of enzymes in the
`
`presence of ethanol which is 5.86 mfi/min/1.
`
`In
`
`chronical experiments upon introduction of ethanol
`
`(passive alcoholization) over the period of 1.5 months
`
`20
`
`of a daily administration of a 15% ethanol and ethanol
`
`in combination with the composition according to the
`
`present invention in the test does of 1 g/kg the data
`
`have been obtained which prove the results of the
`
`previous experiment (see Table 4).
`
`H-9
`
`
`
`

`
`20
`
`Table 3
`
`Effect of
`
`the composition according to the present
`
`-2
`
`invention on elimination of ethanol after the addition
`
`of a 25: ethanol 4.5 g/kg of the animals‘ bodyweiqht-
`
`
`
`Experiment
`
`Statistical
`parameter
`
`Content of
`ethanol in
`blood, %
`
`
`
`1. Digested content (in-
`
`troduction of a 25%
`
`ethanol)
`
`7
`
`M;m
`
`O.72:0.14
`
`2. 3-months‘ consumption
`
`of a 15% ethanol (in-
`
`troduction of 25% et-
`hanol)
`14
`
`3. 3—nonths' consumption
`
`of e 15% ethanol in
`
`combination with the
`
`composition of the
`
`present invention
`
`Mim
`
`1.0:O.14
`
`(administration of 11
`
`25% ethanol)
`
`31$
`
`9
`
`2«5210-57
`
`0-01
`
`4. 3-months‘ consumption
`
`Of a 15% ethanol in
`
`combination with the
`
`composition of this
`
`invention (administ-
`ration of 25% ethe—
`nol + composition),
`
`1:50
`
`11
`
`firm
`P
`
`4-25:0-78
`0-001
`
`
`
`

`
`m
`
`21
`
`Table 4
`
`Activity of aicoholdehydzogenase in blood serum and
`
`liver upon administration of a 15% ethanol
`
`in
`
`combination with the composition according to the
`
`present invention orally for 1.5 months.
`
`A°t“dtY°f
`al°m“fl '
`denydrogenese
`in blood
`
`Activity of alcohol- Ethanol in
`dehydrogenase accord
`blood
`ing to Bonischoen
`me thod
`
`I
`
`serum by the
`Skursky method
`mnzmin/1
`
`1. 155 etLa-i
`n01»
`| 3-‘i1.17
`15% etha—\
`nol+com-;
`position 1
`
`2.
`
`_
`Lnrer.
`Serum
`mmrmin/1 mfi/min/1
`
`>1 ml
`
`3.15¢o.14
`
`47.02:1.91
`
`16.21i1.4
`
`2-7510.33
`
`2.21¢o.o5 34.39i2.6
`
`4.32¢o.4
`
`2-5110.29
`2-5:0.33
`
`2.51¢o.o6 4o.5i3.29
`2.46:0.09 4o.51¢z.3
`
`4.9¢o.6
`4.14:o.3
`
`II I II
`
`of this
`inventi-
`on
`
`3. Composi-
`tion of
`this in-
`vention
`(aqueous
`solution
`1:50)
`
`4. Physiolo-
`gical so-
`lution
`5- Intact
`
`I
`[2-63:0-49
`
`2.s6;o.05 37.4¢1.61
`
`21.s7¢2.5
`
`

`
`32
`
`Under conditions of free choice between a 15%
`
`ethanol and water (control group) and between a 15%
`
`ethanol with the composition according to the
`
`5
`
`invention and water after 1.5 and 3 months of
`
`U1
`
`consumption the activity of alcohol dehydrogenase was
`
`studied prior to and after deprivation.
`
`The results
`
`thus obtained are shown in Table 5.
`
`TABLE 5
`
`Activity of alcoholdehydrogenase at a free choice
`
`of
`
`the test solutions
`
`
`
`
`
`
`1.5 months of
`consumption
`
`3 months of
`consumption
`
`
` after
`prior to
`prior to
`oepriva—
`depri-
`depriva-
`
`
`tion
`tion
`vation
`
`
`
`1.
`
`¢-
`
`75% ethanol +
`
`15% ethanol
`
`2.7i0.26 3.61:O.48 2.64:0.27
`
`
`composition of
`i
`this invention 1.87iO.22|3.35¢0.44 3.95:0.66
`
`
`
`3- Intact
`4.33_+_1.o8 4.79_+o.64 2.2__-50.28
`3.08-1-0.58
`
`
`IL
`
`

`
`23
`
`Therefore.
`
`the composition additive according to the
`
`present invention decelerates oxidation of ethanol
`
`in
`
`the liver by inhibiting activity of alcohol
`
`dehydrogenase.
`
`Observations were carried out to study the lipoid
`
`and carbohydrate metabolism in animals upon
`
`administration of the composition according to the
`
`present
`
`invention against the background of a 3- and
`
`6-months' alcoholization.
`
`To this end. over the period
`
`10
`
`of
`
`3 and 6 months the rats were intragastrically
`
`administered with 2 ml of
`
`the hereinbe1ow—specified
`
`solutions per 100 q of the body mass.
`
`In the control:
`
`Group 1 distilled water: Group II — 15% ethanol: Group
`
`III — 15% ethanol containing a 5% composition according
`
`to the present invention; Group IV - aqueous solution
`
`of
`
`the composition according to the present invention.
`
`The results thus obtained are shown in Tables 6. 7,
`
`8 and 9 hereinbelow.
`
`1‘
`
`LE‘
`
`
`
`

`
`Variation of the content of neutral lipoidu in the liver of rats fed with the solutions
`for 3 months (in % of the total lipoidn, Qim)
`
`'i'.1|Il(- (1
`
`I
`
`C r o u p n
`II
`
`o f
`III
`
`a n i m a l s
`IV
`
`control
`
`distillate
`
`15% ethan01+
`aqueous solution
`of the comp0uiti— 0
`9-
`-0
`on of this inven-
`C mpo ltl n
`mm
`°f 32.11.33-
`
`V
`
`15% ethanol
`
`15,011.21
`12.510.48
`12.5iO.93
`14-510.49
`Cholesterol esters
`103
`B5
`86
`100
`% of variation
`20.1+1_O4 3)
`20.6+1.7T 3)
`20.1+0.84 3)
`1T.211.112)
`Triglycerides
`148
`151
`143
`127
`% of variation
`10.6_+_0.92 ”
`11510.53
`12.3¢0.50
`12,010.40
`Free fat acids
`_
`33
`90
`96
`100
`% of variation
`15.§11.22
`14.210.6T 1)
`16.1¢O.91
`17.21O.53
`Cholesterol
`92
`86
`97
`104
`% of variation
`Residual fraction
`32.5:1.05
`38.310.9T
`39.0;1.02
`41.211.30
`39.011.00
`
`
`:
`
`_
`
`?Z
`
`14,511.10
`
`13.E10.55
`
`1
`
`12.811.60
`
`16.6:O.9
`
`2) 1:40.02;
`1) P .:o.o5;
`p - probability
`
`3) 24.0.01
`
`

`
`'!'.-Ihll‘ ?
`
`Variation of Lhe content of neutral lipoido in the liver of rated feci with the
`em1u‘t:i.one: for 6 months (in ‘)5 of the total lipoids. 111m)
`
`Control
`
`I
`
`II
`
`Groups
`
`of
`
`Neutral Illpoidfi
`
`distillate
`
`15% ethanol
`
`cholesterol esters 16.91059
`K: of variation
`Triglycerides
`96 of variation
`Free fatty acids
`% of variation
`
`15.161021
`
`16.671o.4B
`
`16.‘3210.'?0
`99
`13.831312
`92
`1'r.21_.:0.11
`103
`
`_
`1E.E2_+_0.35
`100
`1a.19¢o.25‘)
`‘I20
`14.01049”
`84
`
`animals
`III
`
`1552’: ethaz_Iol+
`composition
`C’:
`thi’§' 1”‘
`‘''‘”“31°"
`
`16.T4;_l_0.27
`100
`14.1a¢o.22‘)
`94
`17.301037
`104
`
`IV
`
`aqueous fl01u_
`tion of the
`composition
`of the inven-
`tion
`15.81;Ir_0.‘N|
`95
`13.641042 1)
`90
`18.6610.88
`112
`
`if
`
`17.0610.19
`15.7210.39
`'|6.61i0.59
`17.0710.16
`Cholesterol
`99
`97
`96
`99
`% of variation
`Residual fraction
`333310.40
`353810.74
`34.58,1_0.47
`35.06_+_0.52
`343310.61
`
`
`17.283-_0.26
`
`1}
`2)
`
`P435053
`p<o.o2
`
`

`
`Variation of activity of lyaoaomal hydrulases in the liver of rats upon con—
`sumption of ethanol and the compoaition of this invention for 3 months
`and 6 months (nunomol/ml/min,m1mJ
`
`Groups of animals
`
`3 montha
`
`6
`
`months
`
`_fi— galactonidaac
`O.3310.0l
`03510.01
`106
`
`J6~g1uco0idnse
`D.4910.05
`093410.00
`110
`
`J9—ga1act00idnse
`0.3510.O1
`041310.02
`78
`
`J9— glycouidaue
`0.471G.G4
`0.43_1_0.01
`91
`
`0.58:0.08
`
`1)
`
`123
`
`0.50_t0.05
`106
`
`Control
`1. Distillate
`% of variation
`of the control
`II. 15 % ethanol
`% of variation
`of the control
`III. 15 95 ethanol + com-
`pofiiflon of this in_
`vention
`% of variation of
`the control
`IV. Aqueous solution of
`composition 01’ this
`invention
`% of variation of the
`control
`85
`94
`78
`70
`
`
`O.3710.04
`
`U.8710.09
`
`112
`
`178
`
`03510.06
`106
`
`O.6610.0EI
`135
`
`2)
`
`1)
`
`_
`
`O.8610.O6
`
`3)
`
`93
`
`247
`
`02610.01
`75
`
`0.25_1_0.01
`
`1)
`
`04010.02
`
`03110.03
`
`0.3.-3_+_0.05
`
`1} D¢:0.05;
`
`2) P:;0.01;
`
`3) D4:O.001
`
`1:
`
`

`
`£5‘
`
`'l'.'I 1: I v '1
`
`Variation of tho conteril. of carbohydra1.e-contaiuint; siinpuilymers. in the 1:'1.\rer of
`rats fed with ethanol and with. the con: ouition of the invention for 3 r:1ontl1::
`and 6 nronths
`in‘-_-_—%, Him)
`
`
`Groups of
`animals:
`
`
`llexoacs
`
`3 mon1;l1s;
`
`llexoaamines
`
`Iiuxoses
`
`6 months
`
`?
`liexonaniinesi
`
`1. control
`2. Distillate
`35 of variation
`of the control
`
`26.6£111.54
`1B.6T11.‘I2”
`
`70
`
`3. Aqueous solution
`of the composition
`of this invention
`3:3 of variation of
`the control
`
`1)
`
`333512-73
`125
`
`325312.31’
`29.c.u12.52-
`
`91
`
`36.02114?
`111
`
`26.:56—:1.«13
`20.45_-u_1.?2
`
`T8
`
`2B.9111.34
`110
`
`4. 15?; ethanol + c_:om—
`193111.10"
`234012.65
`ia.43;1.271)
`§f13:r*1fi';n°f this
`95 of variation
`75
`B6
`59
`of the control
`5.
`15% ethanol
`15.61+_1.22”
`253431.77“
`153211.002’
`9% of variation
`01‘
`the control
`62
`79
`E2
`
`
`1) P.-.—_:0.05;
`
`2)
`
`p-=:0.0l;
`
`3) p«-.:0.oo1
`
`£3
`
`4'3.0U11.76
`6.ri.53_+_6.972)
`
`140
`
`102.43;'r.633)
`209
`
`34.72+4.213’
`_
`173
`1)
`30.221541”
`62
`
`

`
`28
`
`Then we have carried out pharmacological tests of
`
`the composition according to the present invention as an
`
`agent for improving general resistance of
`
`the organism.
`
`For this purpose the effect of the composition according
`
`LJI
`
`to the present invention on the heat—resistance of rats
`
`has been studied.
`
`{1) Overheating of nondescript female rats (60
`
`animals)
`
`is effected by irradiation with an UHF—Eie1d by
`
`means of an instrument for a microwave therapy with the
`
`frequency of 2.375 mH2 — 17 mA for 10 days once a day
`
`over
`
`the period of 4 days.
`
`The test composition is
`
`administered in the dose of 2.5 ml/kg (intragastrically
`
`in all series of experiments) for 5 days before the
`
`beginning of
`
`irradiation and. on the say of experiment.
`
`one hour before irradiation.
`
`The death rate of rats is
`
`assessed after a 4~times'
`
`irradiation.
`
`It has been found that during one day after the last
`
`irradiation in the control group 22% of the animals
`
`died, whereas among the rats administered with the
`
`20
`
`composition according to the present
`
`invention the death
`
`rate was 11% {p< 0.01).
`
`(2) Overheating of male rats of
`
`the Wistar line is
`
`effected in a
`
`thermostatted cabinet at the temperature
`
`of 43°C.
`
`The test composition in the dose of 2.5 ml/kg
`
`
`
`

`
`29
`
`'
`
`(‘.1
`
`is administered for the preventive purposes over the
`
`period of 20 days.
`
`The rectal temperature and death
`
`rate of the animals are assessed.
`
`It has been found that in the control group 76% of
`
`5
`
`the animals (28 animals out of 37) died. while against
`
`the background of
`
`the composition according to the
`
`present invention 56% of
`
`the rats died (22 rats out of
`
`39: p< 0.001).
`
`The composition'provided no effect on
`
`the rectal temperature.
`
`10
`
`(3) Under
`
`the same conditions of overheating or male
`
`rats of the wistar line the composition according to the
`
`present invention is administered prophylactically over
`
`48 days in the dose of 1 ml/kg.
`
`It has been found that in the control group 54% of
`
`15
`
`rats (30 animals out of 55) died, while upon overheating
`
`against the background of a long—time administration of
`
`the composition according to the present invention the
`
`death rate was 42% (24 rats out of 57;
`
`p (0.001).
`
`(4) Overheating of male rats of the Wistar line was
`
`20
`
`effected in much the same manner.
`
`The test composition
`
`N
`
`was administered in the dose of 1 ml/kg 50 minutes prior
`
`to overheating.
`
`The overheating duration is 40 minutes
`
`

`
`30
`
`and 2 hours.
`
`The animals were killed by decapitation.
`
`Tested were:
`
`the content of glycogen {herein and in
`
`other cases — by the Zeifter method):
`
`activity of
`
`hexokinase and g1ucoso-6—phosphatedehydrogenase {herein
`
`and in other cases — by the formation of nicotinamide—
`
`dinuoleotidephosphoric acid (NADPH).
`
`It has been found that in overheating of
`
`the rats
`
`for 40 minutes the composition inhibited the drop of
`
`the
`
`content of glycogen, as well as of
`
`the activity of
`
`hexokinase and glucosewfi-phosphate dehydrogenase in the
`
`liver (see Table 10 hereinbelow).
`
`L_.rl
`
`10
`
`Upon overheating for 2 hours the test composition
`
`provided no effect on the level of
`
`the studied
`
`parameters.
`
`Overcooling of male rats of
`
`the Wistar line was
`
`caused by placing the animals into a refrigerator
`
`chamber at a
`
`temperature of 5°C for 1 and 2 hours.
`
`The
`
`compos

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket